Site Map sitemap   |  Login login

Company / Advisory Board

Advisory Board

Dr. Adrian Bot

Dr. Adrian Bot is the General Manager of the National Institute for Research and Development of Isotopic and Molecular Technologies (INCDTIM) Cluj-Napoca. He has over 30 years of experience in operational and senior management positions with INCDTIM, being currently responsible for entire management, R&D directions and strategically important integrated research programs. He spent the last 8 years as General Manager, leading INCDTIM through the transition to become one of the best research and development entities from Romania. Dr. Bot has gained a wide experience in the technology transfer and has expert knowledge in coordinating projects in their progression towards industrial phases. Dr. Bot earned Master and Ph.D degrees in Electric Engineering and has held several teaching appointments at Technical University, Cluj-Napoca. He is associated with an outstanding track record of productivity being author and/or co-author of one book and more than 50 articles and proceedings. Additionally, he serves as the president of INCDTIM’s Board and has a strong experience in adding value to R&D organizations through active participation in Advisory Boards. Dr. Adrian Bot is president or permanent member of the organizing committee of different international research events. (PIM, RoLCG, etc.).

Dr. Piotr Bryla

Dr. Piotr Bryla is President of Bryla CMC-Reg Consulting, LLC. In his current role, he brings strategically and scientifically sound technical drug substance and drug product advances, global CMC regulatory planning, submission, preparations and interaction with regulatory authorities, and quality control solutions for small molecules, semisynthetic peptides and monoclonal antibodies. Prior to that, Dr. Bryla held leadership positions, including Vice President of Manufacturing and Process Development at Lux Biosciences and CMC management positions at Omeros Corporation, Barrier Therapeutics, Forest Laboratory, Bayer Corporation and Hoffmann-LaRoche. He received Ph.D. degree in Pharmaceutical Sciences and MS degree in Pharmacy and Pharmaceutical Analysis from Academy of Medicine in Poland, and completed his post-doctoral fellowship in Pharmaceutical Chemistry Department at Rutgers University in the US. Piotr is also the author of more than 20 scientific publications in scientific literature, as well as numerous internal reports, posters and presentations. Dr. Piotr Bryla is a certified member of the Worldwide Who's Who Professional Organization."
Contact us: tel/fax: +4(0)364.439.995